What is Pet Veterinary Drug?
Pet veterinary drug is the category of medicine that deals with the prevention, disorder, and injury in animals and diagnosis and treatment of disease. Among pet veterinary drugs some are similar to human drugs, with development have created a number of specialties within the field, that include areas of expertise such as internal medicine, ophthalmology, surgery, radiology, dermatology, anesthesiology, neurology, and oncology, as well as emergency care.
Global Pet Veterinary Drug Market Outlook
The increasing number of millennial pet parents and the trend of health and wellness are reshaping the pet veterinary drug market. New innovation in the pet care world like health-related pet tech, nutrition apps, veterinary telemedicine, and fitness trackers will have influencing effects growth on the market. Furthermore, pet health care has marked an impressive degree of comparability to human health care. Increasing awareness associated with pet care is fuelling growth. For instance, Tufts at Tech Community Veterinary Clinic in Worcester, Mass., developed in collaboration with a veterinary school. This collaboration will allow students to gain hands-on experience while working toward a traditional diploma and an approved veterinary assistant certificate from the National Association of Veterinary Technicians in America (NAVTA). Increasing approvals by the FDA for the treatment and control of animal decease is creating new exploring applications and shares value.
Controversies associated with indiscriminate usage by non-registered and untrained practitioners is leading to frequent cases of drug resistance and treatment failure may restrain the market. As mandated by the Federal Food, Drug, and Cosmetic Act (the act), a new animal drug cannot be sold into interstate commerce unless it is the subject of an approved new animal drug application (NADA). Challenge in the pet veterinary drugs market is a shortage of these drugs and importing issues due to lack of a streamlined process. Also, pet parents are becoming more open to alternative therapies such as aromatherapy (81%), reflexology (79%) or naturopathy, which is hampering the growth of the market.
Global Pet Veterinary Drug Market Competitive Landscape
The "Global Pet Veterinary Drug Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Boehringer Ingelheim International GmbH, Zoetis Animal Healthcare, Bayer AG, Merck Animal Health, Elanco Animal Health Inc., Virbac Group, Ceva, Dechra Pharmaceuticals Plc, Vetoquinol and Orion Corporation. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL PET VETERINARY DRUG MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources
4. GLOBAL PET VETERINARY DRUG MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL PET VETERINARY DRUG MARKET, BY PRODUCT TYPE
5.1. Overview
5.2. Anti-Infectives
5.3. Anti-Inflammatory
5.4. Parasiticides
5.5. Analgesics
5.6. Sedatives
5.7. Others
6. GLOBAL PET VETERINARY DRUG MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.2. Veterinary Hospitals
6.3. Veterinary Clinics
6.4. Drug Stores
7. GLOBAL PET VETERINARY DRUG MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
8. GLOBAL PET VETERINARY DRUG MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. Boehringer Ingelheim International GmbH
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Zoetis Animal Healthcare
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Bayer AG
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. Merck Animal Health
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Elanco Animal Health Inc.
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
9.6. Virbac Group
9.6.1. Overview
9.6.2. Financial Performance
9.6.3. Product Outlook
9.6.4. Key Developments
9.7. Ceva
9.7.1. Overview
9.7.2. Financial Performance
9.7.3. Product Outlook
9.7.4. Key Developments
9.8. Dechra Pharmaceuticals Plc
9.8.1. Overview
9.8.2. Financial Performance
9.8.3. Product Outlook
9.8.4. Key Developments
9.9. Vetoquinol
9.9.1. Overview
9.9.2. Financial Performance
9.9.3. Product Outlook
9.9.4. Key Developments
9.10. Orion Corporation
9.10.1. Overview
9.10.2. Financial Performance
9.10.3. Product Outlook
9.10.4. Key Developments
10. Appendix
10.1. Related Reports
The Clinical Trial Drug Sourcing Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Small Molecule Drug Design Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Protein Drug Screening Validation Database Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
The Cloud Based Drug Discovery Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Chemical Drug CXO Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Drug Management System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturer...
The Drug Safety Monitoring Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The RDC (Radionuclide Drug Conjugate) Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
The Drug Simulation Research and Development Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competit...
The Drug Authentication Technologies Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...